Autoantibody Screening for T1D: What Is It and Who Should Get It?
Type 1 diabetes (T1D) is an autoimmune disease in which your immune system mistakenly attacks your beta cells. Eventually, your…
Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes
Phillip, M, et.al Given the proven benefits of screening to reduce diabetic ketoacidosis (DKA) likelihood at the time of stage…
Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among Centers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Demeterco-Berggren, C, Jacobsen, L, Guttmann-Bauman, I, Ospelt, E, Smego, A, Hannon, T, Aleppo, G, Chouhary, A, Wong, J, Ebekozien, O…
Type 1 Diabetes Screening and Diagnosis
Gomez, P, Sanchez, J KEY POINTS Deciding who and how to screen for T1D has broad clinical and research implications….
Understanding Providers’ Readiness and Attitudes Toward Autoantibody Screening: A Mixed-Methods Study
Ospelt, E, Hardison, H, Rioles, N, Noor, N, Weinstock, R, Cossen, K, Mathias, P, Smego, A, Mathioudakis, N, Ebekozien, O…
Awareness and Attitudes towards Type 1 Diabetes Antibody Screening
Ospelt, E, Hardison, H, Rioles, N, Noor, N, Nelson, G, Levy, C, McKee, A, Antal, Z, Wong, J, Obrynba, K,…
Provider Perceptions of Barriers and Benefits to Type 1 Diabetes Autoantibody Screening
Ospelt, E, Hardison, H, Rioles, N, Noor, N, Crossen, S, Smego, A, Aleppo, G, Friedman, J, Eng, D, Sullivan, C,…
